BioMark Capital
Life sciences investment firm focused on innovative biotechnology and healthcare companies. Invests across therapeutic, diagnostic, and healthcare technology sectors with emphasis on platform technologies.
Location
San Francisco, USA
Founded
2008
AUM
$500M+
Investment Range
$5M - $50M
Focus
biotech-focused
Fund Stages
seed, series-a, series-b, series-c, growth
Investment Thesis
BioMark Capital invests in life sciences companies developing innovative therapeutics, diagnostics, and healthcare technologies. They focus on companies with platform technologies that can generate multiple products or applications, providing capital and strategic support through development milestones.
Team
Partners / Managing Directors (Health & Bio Focus)
- Investment team with life sciences industry experience
- Advisory network of scientific and clinical experts
Other Key Team Members
- Portfolio management and operations team
Focus Areas
- Therapeutics
- Diagnostics
- Healthcare Technology
- Platform Technologies
- Life Science Tools
- Precision Medicine
Notable Exits
- Portfolio companies advancing through clinical development
- Multiple successful financing rounds